351 related articles for article (PubMed ID: 10903002)
1. Review: pathogenesis of gallstones.
Dowling RH
Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():39-47. PubMed ID: 10903002
[TBL] [Abstract][Full Text] [Related]
2. Role of intestinal transit in the pathogenesis of gallbladder stones.
Dowling RH; Veysey MJ; Pereira SP; Hussaini SH; Thomas LA; Wass JA; Murphy GM
Can J Gastroenterol; 1997; 11(1):57-64. PubMed ID: 9113801
[TBL] [Abstract][Full Text] [Related]
3. Mechanism for the transit-induced increase in colonic deoxycholic acid formation in cholesterol cholelithiasis.
Thomas LA; Veysey MJ; Bathgate T; King A; French G; Smeeton NC; Murphy GM; Dowling RH
Gastroenterology; 2000 Sep; 119(3):806-15. PubMed ID: 10982775
[TBL] [Abstract][Full Text] [Related]
4. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
[TBL] [Abstract][Full Text] [Related]
5. Biliary lipid composition in patients with cholesterol and pigment gallstones and gallstone-free subjects: deoxycholic acid does not contribute to formation of cholesterol gallstones.
Gustafsson U; Sahlin S; Einarsson C
Eur J Clin Invest; 2000 Dec; 30(12):1099-106. PubMed ID: 11122325
[TBL] [Abstract][Full Text] [Related]
6. Gallstones during octreotide therapy.
Dowling RH; Hussaini SH; Murphy GM; Besser GM; Wass JA
Metabolism; 1992 Sep; 41(9 Suppl 2):22-33. PubMed ID: 1355588
[TBL] [Abstract][Full Text] [Related]
7. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile.
Hussaini SH; Pereira SP; Murphy GM; Dowling RH
Hepatology; 1995 Dec; 22(6):1735-44. PubMed ID: 7489982
[TBL] [Abstract][Full Text] [Related]
8. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.
Veysey MJ; Malcolm P; Mallet AI; Jenkins PJ; Besser GM; Murphy GM; Dowling RH
Gut; 2001 Dec; 49(6):828-34. PubMed ID: 11709518
[TBL] [Abstract][Full Text] [Related]
9. High level of deoxycholic acid in human bile does not promote cholesterol gallstone formation.
Gustafsson U; Sahlin S; Einarsson C
World J Gastroenterol; 2003 Jul; 9(7):1576-9. PubMed ID: 12854167
[TBL] [Abstract][Full Text] [Related]
10. Deoxycholic acid is not related to lithogenic factors in gallbladder bile.
Jüngst D; Müller I; Kullak-Ublick GA; Meyer G; Frimberger E; Fischer S
J Lab Clin Med; 1999 Apr; 133(4):370-7. PubMed ID: 10218768
[TBL] [Abstract][Full Text] [Related]
11. Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit.
Shoda J; He BF; Tanaka N; Matsuzaki Y; Osuga T; Yamamori S; Miyazaki H; Sjövall J
Hepatology; 1995 May; 21(5):1291-302. PubMed ID: 7737634
[TBL] [Abstract][Full Text] [Related]
12. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
13. Effect of lactulose and fiber-rich diets on bile in relation to gallstone disease: an update.
VanBerge-Henegouwen GP; Portincasa P; van Erpecum KJ
Scand J Gastroenterol Suppl; 1997; 222():68-71. PubMed ID: 9145452
[TBL] [Abstract][Full Text] [Related]
14. Colonic transit influences deoxycholic acid kinetics.
Veysey MJ; Thomas LA; Mallet AI; Jenkins PJ; Besser GM; Murphy GM; Dowling RH
Gastroenterology; 2001 Oct; 121(4):812-22. PubMed ID: 11606495
[TBL] [Abstract][Full Text] [Related]
15. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors.
Marcus SN; Heaton KW
Gut; 1986 May; 27(5):550-8. PubMed ID: 3699564
[TBL] [Abstract][Full Text] [Related]
16. Prolonged large bowel transit increases serum deoxycholic acid: a risk factor for octreotide induced gallstones.
Veysey MJ; Thomas LA; Mallet AI; Jenkins PJ; Besser GM; Wass JA; Murphy GM; Dowling RH
Gut; 1999 May; 44(5):675-81. PubMed ID: 10205204
[TBL] [Abstract][Full Text] [Related]
17. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease.
Xu QW; Shaffer EA
Gastroenterology; 1993 Oct; 105(4):1184-91. PubMed ID: 8405865
[TBL] [Abstract][Full Text] [Related]
18. Modeling plasma lipoprotein-bile lipid relationships: differential impact of psyllium and cholestyramine in hamsters fed a lithogenic diet.
Trautwein EA; Siddiqui A; Hayes KC
Metabolism; 1993 Dec; 42(12):1531-40. PubMed ID: 8246766
[TBL] [Abstract][Full Text] [Related]
19. Slow intestinal transit: a motor disorder contributing to cholesterol gallstone formation in the ground squirrel.
Xu QW; Scott RB; Tan DT; Shaffer EA
Hepatology; 1996 Jun; 23(6):1664-72. PubMed ID: 8675191
[TBL] [Abstract][Full Text] [Related]
20. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
Xu QW; Scott RB; Tan DT; Shaffer EA
Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
